Literature DB >> 24355605

First detection and characterization of an OXA-48-producing Enterobacter aerogenes isolate.

Eva Torres1, Lorena López-Cerero2, María Dolores Del Toro2, Alvaro Pascual3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24355605     DOI: 10.1016/j.eimc.2013.10.008

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


× No keyword cloud information.
  5 in total

1.  MALDI-TOF MS as a Tool To Detect a Nosocomial Outbreak of Extended-Spectrum-β-Lactamase- and ArmA Methyltransferase-Producing Enterobacter cloacae Clinical Isolates in Algeria.

Authors:  Nour Chems el Houda Khennouchi; Lotfi Loucif; Nafissa Boutefnouchet; Hamoudi Allag; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

2.  Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in Spain.

Authors:  María Pérez-Vázquez; Jesús Oteo; Silvia García-Cobos; Belén Aracil; Simon R Harris; Adriana Ortega; Dionisia Fontanals; Juan Manuel Hernández; Sonia Solís; José Campos; Gordon Dougan; Robert A Kingsley
Journal:  J Antimicrob Chemother       Date:  2016-01-13       Impact factor: 5.790

Review 3.  Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.

Authors:  Anne Davin-Regli; Jean-Marie Pagès
Journal:  Front Microbiol       Date:  2015-05-18       Impact factor: 5.640

4.  Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.

Authors:  Eva Raphael; Lee W Riley
Journal:  Front Med (Lausanne)       Date:  2017-10-30

5.  Carbapenem-Resistant Klebsiella aerogenes Clinical Isolates from a Teaching Hospital in Southwestern China: Detailed Molecular Epidemiology, Resistance Determinants, Risk Factors and Clinical Outcomes.

Authors:  De-Yu Ma; Han-Yu Huang; Hua Zou; Meng-Lu Wu; Qiu-Xia Lin; Bo Liu; Shi-Feng Huang
Journal:  Infect Drug Resist       Date:  2020-02-19       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.